[Remote] Senior Director, Value & Access (Pharmaceutical / Payer) at The Lockwood Group, LLC

Remote

Apply Now

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceutical, Payer, Life Sciences, ConsultingIndustries

Skills

Key technologies and capabilities for this role

Market AccessPricing StrategyHealth EconomicsPayer DynamicsReimbursement PathwaysValue-Based ContractingLife SciencesConsultingStrategic PlanningCommunication

Questions & Answers

Common questions about this position

What qualifications are required for the Senior Director, Value & Access role?

Candidates need proven experience in market access, pricing strategy, or health economics in life sciences, strong understanding of payer dynamics and reimbursement pathways, exceptional communication skills, success in client engagement and collaboration, ability to lead projects, and preferably an advanced degree in health policy, business, or life sciences.

What is the salary or compensation for this position?

This information is not specified in the job description.

Is this role remote or does it require office work?

This information is not specified in the job description.

What is the company culture like at Advantage Point Solutions?

The company offers a collaborative culture with a focus on innovation, integrity, and excellence in a dynamic, mission-driven environment.

What makes a strong candidate for this Senior Director role?

A strong candidate will have proven experience in market access or pricing strategy in life sciences, deep knowledge of payer dynamics and value-based models, exceptional communication and leadership skills, and an advanced degree preferred, enabling them to lead strategies and engage stakeholders effectively.

The Lockwood Group, LLC

Healthcare consulting for drug development support

About The Lockwood Group, LLC

The Lockwood Group provides consulting services specifically for the healthcare and pharmaceutical industries, focusing on clients in the later stages of drug development, particularly after Phase 2 clinical trials. The company assists pharmaceutical and biotech firms by creating strategic publication plans that communicate scientific data and research findings accurately and in compliance with regulatory standards. They also support clients during the prelaunch phase of their products by identifying market needs and collaborating through the launch process to ensure success. A unique aspect of The Lockwood Group is its medical animation affiliate, Random42, which produces engaging and scientifically accurate visual content to help convey complex information. Their business model is based on service fees for consulting and project work, with a commitment to delivering high-quality communications and strategic support to help clients thrive in the competitive healthcare landscape.

Stamford, ConnecticutHeadquarters

2007Year Founded

ACQUISITIONCompany Stage

Consulting, HealthcareIndustries

201-500Employees

Benefits

Remote Work Options

Flexible Work Hours

Risks

Emerging firms using AI-driven content creation threaten market share.

Pharmaceutical companies developing in-house teams may reduce demand for external services.

Tightening EU regulatory standards could increase compliance costs.

Differentiation

Specializes in healthcare and pharmaceutical sectors, focusing on advanced drug development stages.

Offers strategic publication plans tailored to specific audiences and regulatory standards.

Provides commercial support during prelaunch, launch, and post-launch phases.

Upsides

Increased demand for digital health solutions boosts growth in medical communications.

Rise of personalized medicine creates opportunities for specialized communication strategies.

Integration of AI enhances publication strategies and data analysis capabilities.

Land your dream remote job 3x faster with AI

Try Jobo Free